Invesco SteelPath业主有限合伙与能源设备主动型ETF PIPE 深 沪
已收盘 02-06 16:00:00 美东时间
26.6232
+0.233
+0.88%
华盛通- 最 高26.6232
- 今 开26.3905
- 成交量 27股
- 最 低 26.6232
- 昨 收 26.3905
- 总市值 5617.50万
- 52周最高 26.6232
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 20.1715
- 委 比 0.00%
- 总股本 211.00万
- 历史最高 26.6232
- 量 比 0
- 振 幅 0.00%
- 历史最低 20.1715
- 每 手 1
- 风险率 0.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Meet Infleqtion: The Sleeping Giant Quantum Stock Flying Under The Radar — For Now
Infleqtion, formerly ColdQuanta, is an under-the-radar quantum computing and sensing company set to go public in the coming weeks via SPAC merger with well-known Wall Street dealmaker Michael Klein's Churchill Capital Corp X (NASDAQ:CCCX).
02-07 03:18
MDU Resources Q4 revenue misses estimates
MDU Resources Q4 revenue misses estimates Overview Energy delivery firm's Q4 revenue missed analyst expectations Company acquired 49% stake in Badger Wind Farm Outlook MDU Resources expects 2026 EPS between $0.93 and $1.00 Company plans $560 mln capital investment in 2026 MDU Resources anticipates l
02-05 21:40
BRIEF-Tinybuild Says Rev Slightly Ahead Of Expectations Resulted In Positive EBITDA For H2
BRIEF-Tinybuild Says Rev Slightly Ahead Of Expectations Resulted In Positive EBITDA For H2 Feb 5 (Reuters) - Tinybuild Inc TBLD.L : TINYBUILD, INC. - PRE-CLOSE TRADING UPDATE TINYBUILD INC: PIPELINE FOR 2026 AND BEYOND IS STRONG TINYBUILD: REVENUE SLIGHTLY AHEAD OF EXPECTATIONS RESULTED IN POSITIVE
02-05 15:28
BRIEF-Generate Biomedicines Inc - Announces Initial Public Offering
BRIEF-Generate Biomedicines Inc - Announces Initial Public Offering Feb 4 (Reuters) - GENERATE BIOMEDICINES INC - ANNOUNCES INITIAL PUBLIC OFFERING - SEC FILING GENERATE BIOMEDICINES INC - APPLIES TO LIST ON NASDAQ AS GENB - SEC FILING GENERATE BIOMEDICINES INC - GOLDMAN SACHS & CO,MORGAN STANLEY ,P
02-05 06:59
GRI Bio raises $14.5 mln to fund operations into Q1 2027
GRI Bio raises $14.5 mln to fund operations into Q1 2027 Overview Biotechnology company raised $14.5 mln in gross proceeds to fund operations into Q1 2027 Company announced positive Phase 2a data for GRI-0621 in idiopathic pulmonary fibrosis Cash position expected to fund operations into Q1 2027 Out
02-04 21:56
BRIEF-Pfizer’S Ultra-Long-Acting Injectable Glp-1 RA Shows Weight Loss Results In Phase 2B Trial
BRIEF-Pfizer’S Ultra-Long-Acting Injectable Glp-1 RA Shows Weight Loss Results In Phase 2B Trial Feb 3 (Reuters) - Pfizer Inc PFE.N : PFIZER’S ULTRA-LONG-ACTING INJECTABLE GLP-1 RA SHOWS ROBUST AND CONTINUED WEIGHT LOSS WITH MONTHLY DOSING IN PHASE 2B TRIAL PFIZER’S ULTRA-LONG-ACTING INJECTABLE GLP-
02-03 21:21
Enterprise Products Q4 revenue beats analyst expectations on record volumes
Enterprise Products Q4 revenue beats analyst expectations on record volumes Overview Midstream energy provider's Q4 revenue beat analyst expectations Adjusted EBITDA for Q4 beat analyst expectations Company repurchased $50 mln of common units in Q4 Outlook Enterprise expects organic growth capital i
02-03 19:09
BRIEF-Pharming Group Expects 2026 Revenue At $405-$425 Mln
BRIEF-Pharming Group Expects 2026 Revenue At $405-$425 Mln Feb 3 (Reuters) - Pharming Group NV PHAR.AS : ANNOUNCES 2026 FINANCIAL GUIDANCE AND HIGHLIGHTS RARE DISEASE PIPELINE AT INVESTOR DAY 2026 REVENUE GUIDANCE OF $405-$425 MILLION 2026 OPERATING EXPENSE GUIDANCE OF $330-$335 MILLION Source text:
02-03 14:09
BRIEF-Usa Rare Earth Announces Closing Of $1.5 Billion Pipe Financing
BRIEF-Usa Rare Earth Announces Closing Of $1.5 Billion Pipe Financing Jan 29 (Reuters) - USA Rare Earth Inc USAR.O : USA RARE EARTH ANNOUNCES CLOSING OF $1.5 BILLION PIPE FINANCING Source text: ID:nGNX52Fp1q Further company coverage: USAR.O (( Reuters.Briefs@thomsonreuters.com ;))
01-29 20:29
BRIEF-Vallourec Announce Strategic Partnership With XGS Energy
BRIEF-Vallourec Announce Strategic Partnership With XGS Energy Jan 28 (Reuters) - Vallourec SA VLLP.PA : ANNOUNCE STRATEGIC PARTNERSHIP WITH XGS ENERGY PARTNERSHIP ON THREE-GIGAWATT PIPELINE OF COMMERCIAL GEOTHERMAL PROJECTS ACROSS WESTERN UNITED STATES Source text: ID:nGNX6XDLpk Further company cov
01-29 01:02
